Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
Spero Therapeutics (SPRO) - P/B ratio
P/B ratio as of May 2024 : 0.7789
According to Spero Therapeutics's latest financial reports the company has a price-to-book ratio of 0.7789.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Spero Therapeutics - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.7288 | -38.21% |
| 2022-12-31 | 1.18 | -79.92% |
| 2021-12-31 | 5.87 | 36.71% |
| 2020-12-31 | 4.30 | 73.66% |
| 2019-12-31 | 2.47 | 170.9% |
| 2018-12-31 | 0.9134 | -54.04% |
| 2017-12-31 | 1.99 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 IBM IBM | 6.68 | 757.52% | 🇺🇸 USA |
 Thomson Reuters
TRI | 6.22 | 698.00% | 🇨🇦 Canada |
 Franklin Covey FC | 7.30 | 837.05% | 🇺🇸 USA |